BVF INC/IL Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001056807

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 70 positions · Total reported value $4.00B · Top-10 concentration 61.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.8% · 5 new · 9 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.0% · vs SPY +11.2% · Prev Value $3.14B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, BVF INC/IL disclosed 70 equity positions with a combined reported value of $4.00B. The filing implies a focused portfolio: its ten largest positions account for 61.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were MLTX ($1.31B), RVMD ($171.54M), AXSM ($157.68M). By sector, the heaviest allocations are Health Care 83.7%, Technology 0.1%. Versus the prior quarter, allocation shifted toward Health Care (+0.6pp) and away from Other (-0.6pp).

Versus the prior quarter, BVF INC/IL opened 5 new positions, trimmed 9 and fully exited 2, a turnover rate of 34.8% of positions. The portfolio's overlap with the prior quarter was 83% of names.

The largest new positions opened in Q4 2023 were SNDX ($40.52M), ANNX ($31.78M), ENGN ($20.78M).

Of the 2 positions fully exited versus the prior quarter, the largest were PNT ($70.46M), ACRS ($48.39M), REPL ($36.67M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • SNDX SYNDAX PHARMACEUTICALS INC · $40.52M
  • ANNX ANNEXON INC · $31.78M
  • ENGN ENGENE THERAPEUTICS INC · $20.78M
  • SYRE SPYRE THERAPEUTICS INC · $14.79M
  • VTGN VISTAGEN THERAPEUTICS INC · $10.28M
  • SABS SAB BIOTHERAPEUTICS INC · $6.31M
  • ENGNW ENGENE HOLDINGS INC · $803.59K

Fully Exited (vs previous quarter)

  • PNT POINT BIOPHARMA GLOBAL INC · prev qtr: $70.46M
  • ACRS ACLARIS THERAPEUTICS INC · prev qtr: $48.39M
  • REPL REPLIMUNE GROUP INC · prev qtr: $36.67M
  • JSPR JASPER THERAPEUTICS INC · prev qtr: $6.93M
  • IMUX IMMUNIC INC · prev qtr: $1.69M · history
  • BNOX BIONOMICS LIMITED · prev qtr: $127.90K

Insider Transactions (Form 4)

Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-14 U XOMA Royalty Corp 772,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 412,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 2,773,545 — SEC filing
2026-07-14 U XOMA Royalty Corp 3,635,758 — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 SEC filing

All insider transactions →

Fund Profile

BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 44 positions worth $3.91B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 44 positions · $3.91B reported value (Q2 2026)
  • Top 10 holdings = 65.6% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 14.2%
  • Average position size: $88.89M

Sector Tilt

  • Health Care 91.6%
  • Financials 0.1%
  • Materials 0.0%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q2 2026: 5 new, 6 added, 9 reduced, 2 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.7%
Technology 0.1%
Materials 0.0%
Other 16.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 21.75M $1.31B 32.87%
32.87%
Hold
2 5.98M $171.54M 4.29%
4.29%
Add
3 1.98M $157.68M 3.95%
3.95%
Reduce
4 5.74M $131.73M 3.30%
3.30%
Hold
5 5.16M $131.42M 3.29%
3.29%
Add
6 4.37M $129.00M 3.23%
3.23%
Hold
7 9.14M $128.18M 3.21%
3.21%
Hold
8 2.43M $122.86M 3.08%
3.08%
Reduce
9 7.37M $106.03M 2.65%
2.65%
Add
10 4.01M $81.19M 2.03%
2.03%
Hold
11 1.92M $77.85M 1.95%
1.95%
Hold
12 2.75M $75.69M 1.89%
1.89%
Hold
13 10.33M $75.44M 1.89%
1.89%
Add
14 14.57M $72.86M 1.82%
1.82%
Add
15 8.77M $69.85M 1.75%
1.75%
Reduce
16 3.63M $67.22M 1.68%
1.68%
Hold
17 1.73M $61.52M 1.54%
1.54%
Reduce
18 5.87M $60.99M 1.53%
1.53%
Hold
19 10.40M $60.32M 1.51%
1.51%
Add
20 8.75M $57.74M 1.45%
1.45%
Hold
21 4.58M $49.14M 1.23%
1.23%
Hold
22 4.37M $47.89M 1.20%
1.20%
Hold
23 4.05M $45.21M 1.13%
1.13%
Add
24 3.97M $43.71M 1.09%
1.09%
Add
25 890.07K $41.00M 1.03%
1.03%
Reduce
26 1.88M $40.52M 1.01%
1.01%
New
27 2.74M $37.94M 0.95%
0.95%
Hold
28 24.44M $37.39M 0.94%
0.94%
Add
29 812.99K $33.14M 0.83%
0.83%
Reduce
30 3.20M $32.57M 0.81%
0.81%
Hold
31 1.56M $32.05M 0.80%
0.80%
Hold
32 7.00M $31.78M 0.80%
0.80%
New
33 2.74M $30.80M 0.77%
0.77%
Hold
34 1.51M $26.20M 0.66%
0.66%
Hold
35 8.55M $23.35M 0.58%
0.58%
Hold
36 9.54M $22.52M 0.56%
0.56%
Hold
37 6.85M $22.06M 0.55%
0.55%
Hold
38 2.25M $20.78M 0.52%
0.52%
New
39 750.00K $19.33M 0.48%
0.48%
Hold
40 2.99M $17.43M 0.44%
0.44%
Hold
41 1.52M $17.00M 0.42%
0.42%
Hold
42 687.08K $14.79M 0.37%
0.37%
New
43 3.35M $14.36M 0.36%
0.36%
Hold
44 1.26M $13.79M 0.34%
0.34%
Hold
45 1.69M $13.72M 0.34%
0.34%
Hold
46 300.00K $12.64M 0.32%
0.32%
Hold
47 2.00M $10.28M 0.26%
0.26%
New
48 6.60M $10.22M 0.26%
0.26%
Hold
49 4.77M $9.40M 0.23%
0.23%
Add
50 650.00K $9.06M 0.23%
0.23%
Hold

FAQ

What did BVF INC/IL buy in 2023-Q4?

In its 2023-Q4 13F filing, BVF INC/IL reported 70 equity positions worth $4.00B in aggregate; its largest disclosed positions were MLTX ($1.31B), RVMD ($171.54M), AXSM ($157.68M).

How large is BVF INC/IL's portfolio?

BVF INC/IL reported $4.00B of long equity holdings across 70 positions as of 2023-Q4. Top-10 holdings account for 61.9% of reported value.

What is BVF INC/IL's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bvf-inc-il/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →